| KARYOPHARM THERAPEUTICS |
| USA |
| Gesundheit |
| US48576U2050 / A40YLC |
| 25K0 (Frankfurt) / KPTI (NASDAQ) |
| FRA:25K0, ETR:25K0, 25K0:GR, NASDAQ:KPTI |
| - |
| https://www.karyopharm.co.. |
|
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company focused on discovering, developing, and commercializing therapies for cancer and other serious diseases. Karyopharm Therapeutics Inc. specializes in drugs that target nuclear e..
>Volltext.. |
| 24.61 Mio. EUR |
| 193.15 Mio. EUR |
| 130.38 Mio. EUR |
| -72.96 Mio. EUR |
| -199.84 Mio. EUR |
| -11.44 EUR |
| 227.81 Mio. EUR |
| 48.89 Mio. EUR |
| -58.11 Mio. EUR |
| 0.49 |
| 10.17% |
| -87.6% |
| - |
| - |
| - |
| KARYOPHARM |
| 03.10.26 |